Descrizione Clinica
DAFNEGIN 0.2% VAGINAL DEPARTMENT
active ingredients
100 ml vaginal solution contain cyclopyroxolamine 200 mgExcellent
Polyethyleneglycol 300, polyglycolum, undebenzofene, polysorbate 2O, lactic acid, pink scent, purified water.Therapeutic indications
Helpful in the therapy of vulvo-vaginal affections from Candida; can also be used after other topical therapy, in order to reduce the risk of relapse.Contraindications
Individual hypersensitivity ascertained towards the drug.Population
Apply the vaginal solution daily, preferably in the morning, for a period of 5 days, using the entire bottle with the following modes of use: A) Keep the bottle for the ring and fold the cap until the safety seal breaks. B) Extract the cannula to its stop so as to alert the click of the right positioning. C) Introduce the cannula into the vagina and press the walls of the bottle in order to allow the complete emptying. It is suggested to perform the irrigation operation in a relaxed and slowly position.Conservation
No special precaution: normal storage conditions at room temperature.Warnings
To prevent reinfection, the partner should also be subjected to medical supervision. It is recommended that the patient practice irrigation in a stretched or semi-seduta position trying to maintain the solution for a few minutes in the vagina. The use, especially if prolonged, of drugs for topical use can give rise to phenomena of sensibi|ization. In this case, treatment should be suspended and appropriate therapeutic measures should be taken.Interactions
Not knownEffects
Rarely itching, burning or local irritation.Overdosing
Given the pharmacological characteristics, there are no overdose risks.In intravaginal applications there is no systematic absorption of the preparation. However, as with most medicines, the use in pregnancy should only take place as a result of a rigorous choice of indications, under direct control of the doctor.
Source: Farmadati
